DOI QR코드

DOI QR Code

Relationship between muscle strength and dyslipidemia

근력과 이상지질혈증의 관련성

  • Kim, Seok Hwan (Department of Health Care Administration, Seoyoung University Paju Campus) ;
  • Kim, Mee Ju (Department of Health Administration, Seoul cyber University)
  • 김석환 (서영대학교 파주캠퍼스 보건의료행정과) ;
  • 김미주 (서울사이버대학교 보건행정학과)
  • Received : 2020.09.26
  • Accepted : 2020.11.01
  • Published : 2020.11.30

Abstract

Objectives: This study was attempted to examine the relationship between hand grip strength and dyslipidemia. and it was analyze the effect of hand grip strength on dyslipidemia and discuss the problems that may occur. Methods: The study focused on 'the National Health and Nutrition Survey's 7th Year 1, 2, and 3 (2016-2018)' as their primary data. Among people who measured dyslipidemia and relative hand grip strength, 12,636 people were selected as the final study after excluding missing values. Frequency analysis, mean analysis, and regression analysis was used to determine dyslipidemia and hand grip strength indices according to the subjects' characteristics study and verify the research hypothesis. Results: Outcomes show that 4,542 (35.9%) of the subjects were dyslipidemia, and when the hand grip strength of the subjects increased by 1kg, Dyslipidemia decreased by 0.217 less. The result of subdivided and analyzed dependent variables presented that every time the hand grip strength increased by 1kg, the L-HDL -C decreased by 0.325 less, but it did not affect H-LDL-C and H-TG. Conclusion: In order to reduce dyslipidemia, it is essential to recognize the necessity of muscular exercise and fulfill it. Focus on health care, such as health conditions, health behavior, and make efforts to participate in health education. If so, it is expected to help reduce the economic burden, such as the treatment of dyslipidemia and improve the quality of life free from mechanical circulatory diseases.

Keywords

References

  1. 박선영. (2007). 한국인 이상지질혈증 환자의 치료에서 Atorvastatin과 Rosuvastatin 사용에 대한 후향적 비교 평가[석사학위논문]. 충북: 충북대학교 대학원.
  2. 이상지질혈증 치료지침 제정위원회. (2015). 2015 이상지질혈증 치료지침. Journal of Lipid and Atherosclerosis, 4(1), 61-92. https://doi.org/10.12997/jla.2015.4.1.61
  3. 전미양, 최원희, 서영미. (2017). 한국인의 이상지질혈증 발생 위험 요인 및 약물복용이행 영향 요인 평가: 2013-2015 국민건강영양조사 자료 이용. Journal of Korean Biological Nursing Science, 19(3), 131-140. https://doi.org/10.7586/jkbns.2017.19.3.131
  4. 질병관리청. (2020). 국가건강정보포털. Retrieved from http://health.cdc.go.kr/health/HealthInfoArea/HealthInfo/View.do?idx=15240
  5. Blakeley CE, Rompay MI, Schultz NS, Sacheck JM. (2018). Relationship between muscle strength and dyslipidemia, serum 25(OH)D, and weight status among diverse schoolchildren: a cross-sectional analysis. BMC Pediatrics, 18(1), 23. https://doi.org/10.1186/s12887-018-0998-x
  6. Celis-Morales CA et al. (2017). Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study. Diabetes Care, 40(12), 1710-1718. https://doi.org/10.2337/dc17-0921
  7. Cho YG, Song HJ, Park BJ. (2010). The Comparison of Guidelines for Management of Dyslipidemia and the Appropriateness of Them in Korea. Korean Journal of Family Medicine, 31(3), 171-181. https://doi.org/10.4082/kjfm.2010.31.3.171
  8. Choquette S et al. (2010). Relative strength as a determinant of mobility in elders 67-84 years of age. A nuage study: Nutrition as a determinant of successful aging. The journal of nutrition, health & aging, 14(3), 190-195. https://doi.org/10.1007/s12603-010-0047-4
  9. Cordova CM, Schneider CR, Juttel ID, Cordova MM. (2004). Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients. Arquivos Brasileiros de Cardiologia, 83(6), 482-487;476-481.
  10. Ebrahimi H, Emamian MH, Hashemi H, Fotouhi A. (2016). Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10(3), 149-156. https://doi.org/10.1016/j.dsx.2016.01.009
  11. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. (2008). Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine, 34, 36-51. https://doi.org/10.1007/s12020-008-9100-z
  12. Gale CR, Martyn CN, Cooper C, Sayer AA. (2007). Grip strength, body composition, and mortality. International Journal of Epidemiology, 36(1), 228-235. https://doi.org/10.1093/ije/dyl224
  13. Gaziano JM, Gaziano TA. (2013). What's New With Measuring Cholesterol?. JAMA, 310(19), 2043-2044. https://doi.org/10.1001/jama.2013.282775
  14. Grundy SM et al. (2004). Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology, 44(3), 720-32. https://doi.org/10.1016/j.jacc.2004.07.001
  15. Ishii S, Tanaka T, Akishita M, Ouchi Y, Tuji T et al. (2014). Metabolic Syndrome, Sarcopenia and Role of Sex and Age: Cross-Sectional Analysis of Kashiwa Cohort Study. PLoS One, 9(11), e112718. https://doi.org/10.1371/journal.pone.0112718
  16. Jellinger P, Smith D, Mehta A, Ganda O, Handelsman Y et al. (2012). American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice, 18(1), 1-78. https://doi.org/10.4158/EP.18.S1.1
  17. Kim BM et al. (2020). Association between Relative Handgrip Strength and Dyslipidemia in Korean Adults: Findings of the 2014-2015 Korea National Health and Nutrition Examination Survey. Korean Journal of Family Medicine, 1-8.
  18. Kim HC. (2016). Epidemiology of dyslipidemia in Korea. Journal of the Korean Medical Association, 59(5), 352-357. https://doi.org/10.5124/jkma.2016.59.5.352
  19. Kitamura A et al. (2017). Impact of Hypertension and Subclinical Organ Damage on the Incidence of Cardiovascular Disease Among Japanese Residents at the Population and Individual Levels - The Circulatory Risk in Communities Study (CIRCS). Circulation Journal, 81(7), 1022-1028. https://doi.org/10.1253/circj.CJ-16-1129
  20. Kodama S et al. (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA, 301(19), 2024-2035. https://doi.org/10.1001/jama.2009.681
  21. KOSIS. (2020). 연령별 성별 검진대상 질환력(과거력, 가족력) 문진결과. Retrieved from http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_35007_N043&vw_cd=MT_ZTITLE&list_id=350_35007_A006&seqNo=&lang_mode=ko&language=kor&obj_var_id=&itm_id=&conn_path=MT_ZTITLE
  22. Kwon SY, Na YA. (2012). Comparison of LDL-Cholesterol Direct Measurement with the Estimate using Various Formula. Korean Journal of Clinical Laboratory Science, 44, 103-111.
  23. Lawman HG et al. (2016). Associations of Relative Handgrip Strength and Cardiovascular Disease Biomarkers in U.S. Adults, 2011-2012. American Journal of Preventive Medicine, 50(6), 677-683. https://doi.org/10.1016/j.amepre.2015.10.022
  24. Lee WJ, Peng LN, Chiou ST, Chen LK. (2016). Relative Handgrip Strength Is a Simple Indicator of Cardiometabolic Risk among Middle-Aged and Older People: A Nationwide Population-Based Study in Taiwan. PLoS One, 11(8), e0160876. https://doi.org/10.1371/journal.pone.0160876
  25. Li D, Guo G, Xia L, Yang X, Zhang B et al. (2018). Relative Handgrip Strength Is Inversely Associated with Metabolic Profile and Metabolic Disease in the General Population in China. Frontiers in Physiology, 9, 59. https://doi.org/10.3389/fphys.2018.00059
  26. Li Qi et al. (2015). Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing. China. International Journal of Environmental Research Public Health. 12(10), 13455-13465. https://doi.org/10.3390/ijerph121013455
  27. Monaco MD, Monaco RD, Manca M, Cavanna A. (2000). Handgrip Strength is an Independent Predictor of Distal Radius Bone Mineral Density in Postmenopausal Women. Clin Rheumatol, 19(6), 473-476. https://doi.org/10.1007/s100670070009
  28. Nissen SE et al. (2005). Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease. the New England Journal of Medicine, 352, 29-38. https://doi.org/10.1056/NEJMoa042000
  29. Ochi M et al. (2010). Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis, 212(1), 327-332. https://doi.org/10.1016/j.atherosclerosis.2010.05.026
  30. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW et al. (1999). Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. the New England Journal of Medicine, 341(6), 410-418. https://doi.org/10.1056/NEJM199908053410604
  31. Sarwar N et al. (2007). Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation, 115(4), 450-458. https://doi.org/10.1161/CIRCULATIONAHA.106.637793
  32. Singh IM, Shishehbor MH, Ansell BJ. (2007). High-density lipoprotein as a therapeutic target: a systematic review. JAMA, 298(7), 786-798. https://doi.org/10.1001/jama.298.7.786
  33. Syddall H, Cooper C, Martin F, Briggs R, Aihie Sayer AA. (2003). Is grip strength a useful single marker of frailty?. Age and Ageing, 32(6), 650-656. https://doi.org/10.1093/ageing/afg111
  34. Sayer AA et al. (2007). Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM: An International Journal of Medicine, 100(11), 707-713. https://doi.org/10.1093/qjmed/hcm095
  35. Toth PP, Potter D, Ming EE. (2012). Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006. Journal of Clinical Lipidology, 6(4), 325-30. https://doi.org/10.1016/j.jacl.2012.05.002
  36. Tremblay AJ et al. (2004). Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clinical biochemistry, 37(9), 785-790. https://doi.org/10.1016/j.clinbiochem.2004.03.008
  37. Willey JZ et al. (2014). Population Attributable Risks of Hypertension and Diabetes for Cardiovascular Disease and Stroke in the Northern Manhattan Study. Journal of the American Heart Association, 3(5), e001106. https://doi.org/10.1161/JAHA.114.001106
  38. World Health Organization. (2018). Global Health Observatory (GHO) data. Deaths from NCDs. Retrieved from http://www.who.int/gho/ncd/mortality_morbidity/ncd_total/en/index.html
  39. Wu Y, Wang W, Liu T, Zhang D. (2017). Association of Grip Strength With Risk of All-Cause Mortality, Cardiovascular Diseases, and Cancer in Community-Dwelling Populations: A Meta-analysis of Prospective Cohort Studies. Journal of the American Medical Directors Association, 18(6), 551.e17-551.e35. https://doi.org/10.1016/j.jamda.2017.03.011
  40. Yang YS, Lee SY, Kim JS, Choi KM, Lee KW et al. (2020). Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments. Endocrinology and metabolism, 35(2), 367-376. https://doi.org/10.3803/enm.2020.35.2.367